Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancerWei Wei, Lingying Wu, Ning Li et al.|Oncotarget|2016Cited by 61
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolismBin Li, Haitao Liu|Acta Pharmaceutica Sinica B|2024Cited by 33
Discussion on Current Pollution Status andLegislation of Environmental Hormone in ChinaYuanyuan Zeng, Hui Wang, Haitao Fan et al.|Procedia Environmental Sciences|2011Cited by 10
GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activationMiao Ao, Bin Li, Haihua Xiao et al.|Nano Today|2025Cited by 8
Corrigendum to “GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activation” [Nano Today 62 (2025) 102729]Miao Ao, Bin Li, Hongyi Hou et al.|Nano Today|2025Cited by 0